Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does OMEPRAZOLE Cause Product use issue? 949 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 949 reports of Product use issue have been filed in association with OMEPRAZOLE (omeprazole sodium bicarbonate). This represents 1.1% of all adverse event reports for OMEPRAZOLE.

949
Reports of Product use issue with OMEPRAZOLE
1.1%
of all OMEPRAZOLE reports
58
Deaths
234
Hospitalizations

How Dangerous Is Product use issue From OMEPRAZOLE?

Of the 949 reports, 58 (6.1%) resulted in death, 234 (24.7%) required hospitalization, and 21 (2.2%) were considered life-threatening.

Is Product use issue Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for OMEPRAZOLE. However, 949 reports have been filed with the FAERS database.

What Other Side Effects Does OMEPRAZOLE Cause?

Chronic kidney disease (35,759) Acute kidney injury (19,260) Renal failure (14,721) End stage renal disease (10,356) Renal injury (9,482) Tubulointerstitial nephritis (4,809) Drug ineffective (4,355) Gastrooesophageal reflux disease (3,929) Pain (3,602) Nephrogenic anaemia (2,873)

What Other Drugs Cause Product use issue?

INFLIXIMAB (12,752) DUPILUMAB (10,575) POLYETHYLENE GLYCOL 3350 (9,432) METHOTREXATE (8,185) DICLOFENAC (8,009) RITUXIMAB (6,948) ADALIMUMAB (6,379) ETANERCEPT (6,062) TOCILIZUMAB (5,944) ABATACEPT (5,915)

Which OMEPRAZOLE Alternatives Have Lower Product use issue Risk?

OMEPRAZOLE vs OMEPRAZOLE\SODIUM BICARBONATE OMEPRAZOLE vs OMNIPAQUE OMEPRAZOLE vs OMNISCAN OMEPRAZOLE vs ONABOTULINUMTOXINA OMEPRAZOLE vs ONASEMNOGENE ABEPARVOVEC

Related Pages

OMEPRAZOLE Full Profile All Product use issue Reports All Drugs Causing Product use issue OMEPRAZOLE Demographics